MANCINI, NICASIO
 Distribuzione geografica
Continente #
EU - Europa 917
NA - Nord America 716
AS - Asia 123
SA - Sud America 8
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 4
AF - Africa 1
Totale 1.773
Nazione #
US - Stati Uniti d'America 712
SE - Svezia 574
IT - Italia 219
CN - Cina 64
FI - Finlandia 35
IE - Irlanda 34
DE - Germania 24
SG - Singapore 21
IN - India 13
IR - Iran 9
SA - Arabia Saudita 7
RO - Romania 6
HU - Ungheria 5
PH - Filippine 5
RU - Federazione Russa 5
AU - Australia 4
BR - Brasile 4
CL - Cile 4
CA - Canada 3
NL - Olanda 3
A1 - Anonimo 2
BE - Belgio 2
CH - Svizzera 2
EU - Europa 2
FR - Francia 2
GB - Regno Unito 2
HK - Hong Kong 2
PL - Polonia 2
HR - Croazia 1
JP - Giappone 1
MX - Messico 1
PK - Pakistan 1
UA - Ucraina 1
ZA - Sudafrica 1
Totale 1.773
Città #
Princeton 153
Lawrence 150
Milan 119
Ashburn 114
New York 78
Shanghai 55
Helsinki 35
Dublin 31
Rome 15
Seattle 10
Turin 9
Los Angeles 8
Pune 8
Washington 8
Jeddah 6
Tehran 6
Budapest 5
Ancona 4
Fremont 4
Quezon City 4
Santiago 4
Ballincollig 3
Bergamo 3
Bologna 3
Busto Arsizio 3
Florence 3
Frankfurt Am Main 3
Genoa 3
Lansing 3
Melbourne 3
Riccione 3
Rockville 3
Sorocaba 3
Varese 3
Vittoria 3
Ascoli Piceno 2
Borås 2
Brugherio 2
Campi Bisenzio 2
Cologne 2
Como 2
Gatchina 2
Ghent 2
Jamshedpur 2
Kunming 2
Las Vegas 2
Naples 2
Singapore 2
Tongling 2
Udine 2
Varedo 2
Verona 2
Zurich 2
Amsterdam 1
Andover 1
Arezzo 1
Bacoor 1
Bari 1
Beijing 1
Bengaluru 1
Bloemfontein 1
Buronzo 1
Central 1
Charlottesville 1
Dresano 1
Frankfurt am Main 1
Guangzhou 1
Hamilton 1
Hanover 1
Isfahan 1
Karachi 1
Kwai Chung 1
London 1
Mazzano Romano 1
Mexico City 1
Naaldwijk 1
Napoli 1
North York 1
Omsk 1
Palaia 1
Palermo 1
Paris 1
Riverside 1
Riyadh 1
San Diego 1
San Donà di Piave 1
Santa Clara 1
Segrate 1
Sheffield 1
Shenzhen 1
St Petersburg 1
Sydney 1
São Paulo 1
Teramo 1
Tokyo 1
Volgograd 1
Yazd 1
Zola Predosa 1
Totale 949
Nome #
A modified Frosch approach for posterior tibial plateau fractures: Technical note and case series 56
Cell-to-cell spread-blocking activity is extremely limited in the sera of HSV-1 and HSV-2 infected subjects 35
Antibody Titer Kinetics and SARS-CoV-2 Infections Six Months after Administration with the BNT162b2 Vaccine 30
Differential composition of vaginal microbiome, but not of seminal microbiome, is associated with successful intrauterine insemination in couples with idiopathic infertility: A prospective observational study 29
Cloning of the first human anti-JCPyV/VP1 neutralizing monoclonal antibody: Epitope definition and implications in risk stratification of patients under natalizumab therapy 27
High Risk of Secondary Infections Following Thrombotic Complications in Patients With COVID-19 25
Biobanking for COVID-19 research 25
Unconventional CD147-dependent platelet activation elicited by SARS-CoV-2 in COVID-19 25
Entry inhibition of HSV-1 and -2 protects mice from viral lethal challenge 23
A Biologically-validated HCV E1E2 Heterodimer Structural Model 23
Levofloxacin prophylaxis vs no prophylaxis in neutropenic patients within an endemic country for carbapenem-resistant GNB 22
JC polyomavirus (JCV) and monoclonal antibodies: friends or potential foes? 22
A phage display vector optimized for the generation of human antibody combinatorial libraries and the molecular cloning of monoclonal antibody fragments 21
Detection of low-level HCV variants in DAA treated patients: comparison amongst three different NGS data analysis protocols 21
A non-VH1-69 heterosubtypic neutralizing human monoclonal antibody protects mice against H1N1 and H5N1 viruses 20
Broadly neutralizing anti-influenza human monoclonal antibodies and their possible role in predictive medicine 19
Combined Prophylactic and Therapeutic Use Maximizes Hydroxychloroquine Anti-SARS-CoV-2 Effects in vitro 19
Nanopore ReCappable sequencing maps SARS-CoV-2 5' capping sites and provides new insights into the structure of sgRNAs 19
Answer to Photo Quiz: Scolecobasidium sp 19
A Human Stem Cell-Derived Neurosensory–Epithelial Circuitry on a Chip to Model Herpes Simplex Virus Reactivation 18
A potential role for monoclonal antibodies in prophylactic and therapeutic treatment of influenza 18
Microbiome Markers are Early Predictors of Acute GvHD in Allogeneic Hematopoietic Stem Cell Transplant recipients 18
Weak correlation between antibody titers and neutralizing activity in sera from SARS-CoV-2 infected subjects 18
Novel therapeutic investigational strategies to treat severe and disseminated HSV infections suggested by a deeper understanding of in vitro virus entry processes 18
Cardiac implantable electronic device infections: impact of initiation of antimicrobial treatment before or after device removal on microbiological yield 17
A Human Monoclonal Antibody with Neutralizing Activity against Highly Divergent Influenza Subtypes 17
Interferon-β 1a inhibits SARS-CoV-2 in vitro when administered after virus infection 17
Chimeric antigen receptor (CAR)-engineered T cells redirected against hepatitis C virus (HCV) E2 glycoprotein 17
Viral Respiratory Pathogens and Lung Injury 17
Broadly neutralizing human monoclonal antibodies: a novel resource against influenza viruses 17
Circulating SARS-CoV-2 variants in Italy, October 2020–March 2021 17
Adoptive T-cell therapy in the treatment of viral and opportunistic fungal infections 16
Analysis of the faecal microbiome during analytical treatment interruption in people with chronic HIV infection and long-lasting virological suppression (APACHE study) 16
Adjuvant role of SeptiFast to improve the diagnosis of sepsis in a large cohort of hematological patients 16
Mechanisms of Hepatitis C Virus Escape from Vaccine-Relevant Neutralizing Antibodies 16
The efficacy of ultraviolet light-emitting technology against coronaviruses: a systematic review 16
The interferon landscape along the respiratory tract impacts the severity of COVID-19 16
COVID-eVax, an electroporated DNA vaccine candidate encoding the SARS-CoV-2 RBD, elicits protective responses in animal models 15
Influenza B-cells protective epitope characterization: a passkey for the rational design of new broad-range anti-influenza vaccines 15
HUMAN MONOCLONAL ANTIBODY ENDOWED WITH ANTI-HSV-1 AND -2 ACTIVITY STRONGLY INHIBITS VIRUS REPLICATION 15
Characterization of two human monoclonal anti-E2/HCV antibodies for potential application in prevention and treatment of HCV infection 15
Neutralization Interfering Antibodies: a "Novel" Mechanism of Humoral Immune Mutiny and Viral Evasion? 15
Epitope mapping by epitope excision, hydrogen/deuterium exchange, and peptide-panning techniques combined with in silico analysis 15
Answer to February 2019 Photo Quiz: Neurological Symptoms in a 74-Year-Old Diabetic Woman Admitted to the Emergency Room 15
IFCC interim guidelines on molecular testing of SARS-CoV-2 infection 15
Improving the Diagnostic Algorithm for Sepsis: Adjuvant Role of SeptiFast in 491 Consecutive Hematological Patients 15
Proper Selection of In Vitro Cell Model Affects the Characterization of the Neutralizing Antibody Response against SARS-CoV-2 14
Acute respiratory distress in a neutropenic febrile patient after hematopoietic cell transplantation 14
ANTI-HIV-1 RESPONSE ELICITED IN RABBITS BY ANTI-IDIOTYPE MONOCLONAL ANTIBODIES MIMICKING THE CD4-BINDING SITE ON GP120 14
Fast inactivation of SARS-CoV-2 by UV-C and ozone exposure on different materials 14
Longitudinal microbiome profile associates with the risk of major transplant-related complications in allogeneic HSCT recipients 14
Heparin Inhibits Cellular Invasion by SARS-CoV-2: Structural Dependence of the Interaction of the Spike S1 Receptor-Binding Domain with Heparin 14
Characterization of a lineage c.36 sars-cov-2 isolate with reduced susceptibility to neutralization circulating in lombardy, italy 14
IFCC interim guidelines on rapid point-of-care antigen testing for SARS-CoV-2 detection in asymptomatic and symptomatic individuals 14
Harmonization of six quantitative SARS-CoV-2 serological assays using sera of vaccinated subjects 14
Characterization of epitopes recognized by monoclonal antibodies: experimental approaches supported by freely accessible bioinformatic tools 13
Antigen-driven evolution of B lymphocytes in coronary atherosclerotic plaques 13
Anti-HIV-1 response elicited in rabbits by anti-idiotype monoclonal antibodies mimicking the CD4-binding site 13
Early molecular diagnosis of aspergillosis in a patient with acute myeloid leukaemia 13
IN VIVO PROTECTION CONFERRED BY HUMAN MONOCLONAL ANTIBODY DIRECTED AGAINST HSV-1 AND 2 13
A case of psoriatic arthritis triggered by SARS-CoV-2 infection 13
Facing the Rising Tide of Multidrug Resistant Gram-Negative Pathogens in Allogeneic HSCT with Nanosphere's Verigene((R)) System 13
Very high SARS-CoV-2 load at the emergency department presentation strongly predicts the risk of admission to the intensive care unit and death 13
Global and local envelope protein dynamics of hepatitis C virus determine broad antibody sensitivity 13
Differential plasmacytoid dendritic cell phenotype and type I Interferon response in asymptomatic and severe COVID-19 infection 13
Antibiotic appropriateness for Gram-negative bloodstream infections: impact of infectious disease consultation 12
HCV E2 core structures and mAbs: something is still missing 12
An outbreak caused by multidrug-resistant OXA-58-positive Acinetobacter baumannii in an intensive care unit in Italy 12
Synergy evaluation of anti-Herpes Simplex Virus type 1 and 2 compounds acting on different steps of virus life cycle 12
Role and potential therapeutic use of antibodies against herpetic infections 12
Phage display for the production of human monoclonal antibodies against human pathogens 12
Naringenin is a powerful inhibitor of SARS-CoV-2 infection in vitro 12
Interferon β-1a (IFNβ-1a) in COVID-19 patients (INTERCOP): study protocol for a randomized controlled trial 12
Photo quiz: Neurological symptoms in a 74-year-old diabetic woman admitted to the emergency room 12
In Vitro Antimicrobial Activity of the Siderophore Cephalosporin Cefiderocol against Acinetobacter baumannii Strains Recovered from Clinical Samples 12
Smallpox vaccination-elicited antibodies cross-neutralize 2022-Monkeypox virus Clade II 11
A novel expression vector for production of epitope-tagged recombinant Fab-fragment in bacteria 11
Antithrombotic therapy in patients with COVID-19? -Rationale and Evidence- 11
Maturation signatures of conventional dendritic cell subtypes in COVID‐19 suggest direct viral sensing 11
Antibiotic resistance among sexually transmitted infections: perspectives from clinical practice 10
Dose-Dependent Impairment of the Immune Response to the Moderna-1273 mRNA Vaccine by Mycophenolate Mofetil in Patients with Rheumatic and Autoimmune Liver Diseases 10
A closer look at prion strains: Characterization and important implications 10
Enteric microbiome markers as early predictors of clinical outcome in allogeneic hematopoietic stem cell transplant (allo-HSCT): results of a prospective study in adult patients 10
Control of infectious mortality due to carbapenemase-producing Klebsiella pneumoniae in hematopoietic stem cell transplantation 10
Direct sequencing of Scedosporium apiospermum DNA in the diagnosis of a case of keratitis 10
Geographical and temporal distribution of SARS-CoV-2 clades in the WHO European Region, January to June 2020 10
Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility 10
Semen infections in men with primary infertility in the real-life setting 10
Molecular study and epitope mapping of the human antibody response against HCV/E2 glycoprotein by generation of monoclonal recombinant Fabs. 10
Synergistic neutralization of HCV by two broadly neutralizing human monoclonal antibodies 10
Profiling Antibody Response Patterns in COVID-19: Spike S1-Reactive IgA Signature in the Evolution of SARS-CoV-2 Infection 10
Identification of a novel mutation involved in colistin resistance in Klebsiella pneumoniae through Next-Generation Sequencing (NGS) based approaches 9
Genetic characterization of Klebsiella pneumoniae carbapenemase -producing Klebsiella pneumoniae isolates with different susceptibility to ceftazidime/avibactam in patients with blood-stream infections 9
Clinical characterization and whole genome sequence-based typing of two cases of endophthalmitis due to Listeria monocytogenes 9
Heterosubtypic protection conferred by the human monoclonal antibody PN-SIA28 against influenza A virus lethal infections in mice 9
Heterogeneity of the humoral anti-HCV/E2 response in persistently infected patients as demonstrated by divergent patterns of inhibition of the binding of anti-HCV/E2 human monoclonal antibodies 9
Molecular Diagnosis of Scedosporium apiospermum Keratitis. 9
Comparative Evaluation of the Bruker Biotyper and Vitek MS Matrix-Assisted Laser Desorption Ionization–Time Of Flight (MALDI-TOF) Mass Spectrometry Systems for Identification of Yeasts of Medical Importance 9
Risks of "blind" automated identification systems in medical microbiology 9
Coronaviridae and SARS-associated coronavirus strain HSR1 9
Totale 1.541
Categoria #
all - tutte 29.282
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.282


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202019 11 0 0 1 0 0 4 0 0 0 0 3
2020/202157 4 2 0 14 6 9 9 5 0 7 1 0
2021/2022142 3 7 20 29 13 7 13 9 4 10 6 21
2022/20231.082 350 259 98 15 22 127 62 65 49 7 14 14
2023/2024607 27 40 101 92 53 149 34 70 9 23 9 0
Totale 2.026